Vitamin K-Dependent Carboxylation

Vitamins and Hormones

Volumn 78, Issue , 2008, Pages 131-156

  Berkner, Kathleen L ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; GLUTAMYL CARBOXYLASE; LIGASE; PHYTOMENADIONE; PHYTOMENADIONE OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); UNCLASSIFIED DRUG; VITAMIN K GROUP;

ANIMAL; CELL CULTURE; CHEMISTRY; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; REVIEW;

ANIMALS; CARBON-CARBON LIGASES; CELLS, CULTURED; HUMANS; NAD(P)H DEHYDROGENASE (QUINONE); OXIDATION-REDUCTION; VITAMIN K; VITAMIN K 1;

EID: 40949143530     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(07)00007-6     Document Type: Review

References (118)

1. Bandyopadhyay P.K., Garrett J.E., Shetty R.P., Keate T., Walker C.S., and Olivera B.M. Gamma-glutamyl carboxylation: An extracellular posttranslational modification that antedates the divergence of molluscs, arthropods, and chordates. Proc. Natl. Acad. Sci. USA 99 (2002) 1264-1269
2. Bandyopadhyay P.K., Clark K., Stevenson B.J., Rivier J.E., Olivera B.M., Golic K.G., and Rong Y.S. Biochemical characterization of Drosophila gamma-glutamyl carboxylase and its role in fly development. Insect Mol. Biol. 15 (2006) 147-156
3. Begley G.S., Furie B.C., Czerwiec E., Taylor K.L., Furie G.L., Bronstein L., Stenflo J., and Furie B. A conserved motif within the vitamin K-dependent carboxylase gene is widely distributed across animal phyla. J. Biol. Chem. 275 (2000) 36245-36249
4. Berkner K.L. The vitamin K-dependent carboxylase. Annu. Rev. Nutr. 25 (2005) 127-149
5. Berkner K.L., and Pudota B.N. Vitamin K-dependent carboxylation of the carboxylase. Proc. Natl. Acad. Sci. USA 95 (1998) 466-471
6. Berkner K.L., and Runge K.W. The physiology of vitamin K nutriture and vitamin K-dependent protein function in atherosclerosis. J. Thromb. Haemost. 2 (2004) 2118-2132
7. Binkley N.C., Krueger D.C., Engelke J.A., Foley A.L., and Suttie J.W. Vitamin K supplementation reduces serum concentrations of under-γ-carboxylated osteocalcin in healthy young and elderly adults. Am. J. Clin. Nutr. 72 (2000) 1523-1528
8. Booth S.L., and Suttie J.W. Dietary intake and adequacy of vitamin K. J. Nutr. 128 (1998) 785-788
9. Bracey M.H., Cravatt B.F., and Stevens R.C. Structural commonalities among integral membrane enzymes. FEBS Lett. 567 (2004) 159-165
10. Brenner B., Sanchez-Vega B., Wu S.M., Lanir N., Stafford D.W., and Solera J. A missense mutation in gamma-glutamyl carboxylase gene causes combined deficiency of all vitamin K-dependent blood coagulation factors. Blood 92 (1998) 4554-4559
11. Brown M.A., Begley G.S., Czerwiec E., Stenberg L.M., Jacobs M., Kalume D.E., Roepstorff P., Stenflo J., Furie B.C., and Furie B. Precursors of novel Gla-containing conotoxins contain a carboxy-terminal recognition site that directs gamma-carboxylation. Biochemistry 44 (2005) 9150-9159
12. Bush K.A., Stenflo J., Roth D.A., Czerwiec E., Harrist A., Begley G.S., Furie B.C., and Furie B. Hydrophobic amino acids define the carboxylation recognition site in the precursor of the gamma-carboxyglutamic-acid-containing conotoxin epsilon-TxIX from the marine cone snail Conus textile. Biochemistry 38 (1999) 14660-14666
13. Canfield L.M. Vitamin K-dependent oxygenase/carboxylase; differential inactivation by sulfhydryl reagents. Biochem. Biophys. Res. Commun. 148 (1987) 184-191
14. Carlisle T.L., and Suttie J.W. Vitamin K dependent carboxylase: Subcellular location of the carboxylase and enzymes involved in vitamin K metabolism in rat liver. Biochemistry 19 (1980) 1161-1167
15. Carrié I., Portoukalian J., Vicaretti R., Rochford J., Potvin S., and Ferland G. Menaquinone-4 concentration is correlated with sphingolipid concentrations in rat brain. J. Nutr. 134 (2004) 167-172
16. Chu K., Wu S.M., Stanley T., Stafford D.W., and High K.A. A mutation in the propeptide of Factor IX leads to warfarin sensitivity by a novel mechanism. J. Clin. Invest. 98 (1996) 1619-1625
17. Czerwiec E., Begley G.S., Bronstein M., Stenflo J., Taylor K., Furie B.C., and Furie B. Expression and characterization of recombinant vitamin K-dependent gamma-glutamyl carboxylase from an invertebrate, Conus textile. Eur. J. Biochem. 269 (2002) 6162-6172
18. Darghouth D., Hallgren K.W., Shtofman R.L., Mrad A., Gharbi Y., Maherzi A., Kastally R., LeRicousse S., Berkner K.L., and Rosa J.-P. Compound heterozygosity of novel missense mutations in the γ-carboxylase gene causes hereditary combined vitamin K-dependent coagulation factor deficiency. Blood 108 (2006) 1925-1931
19. Davidson R.T., Foley A.L., Engelke J.A., and Suttie J.W. Conversion of dietary phylloquinone to tissue menaquinone-4 in rats is not dependent on gut bacteria. J. Nutr. 128 (1998) 220-223
20. Dowd P., Hershline R., Ham S.W., and Naganathan S. Vitamin K and energy transduction: A base strength amplification mechanism. Science 269 (1995) 1684-1691
21. Ducy P., Desbois C., Boyce B., Pinero G., Story B., Dunstan C., Smith E., Bonadio J., Goldstein S., Gundberg C., Bradley A., and Karsenty G. Increased bone formation in osteocalcin-deficient mice. Nature 382 (1996) 448-452
22. Engelke J.A., Hale J.E., Suttie J.W., and Price P.A. Vitamin K-dependent carboxylase: Utilization of decarboxylated bone Gla protein and matrix Gla protein as substrates. Biochim. Biophys. Acta 1078 (1991) 31-34
23. Esmon C.T., Esmon N.L., Le Bonniec B.F., and Johnson A.E. Protein C activation. Meth. Enzymol. 222 (1993) 359-385
24. Fasco M.J., Principe L.M., Walsh W.A., and Friedman P.A. Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes. Biochemistry 22 (1983) 5655-5660
25. Fourrier F. Recombinant human activated protein C in the treatment of severe sepsis: An evidence-based review. Crit. Care Med. 32 (2004) S534-S541
26. Fregin A., Rost S., Wolz W., Krebsova A., Muller C.R., and Oldenburg J. Homozygosity mapping of a second gene locus for hereditary combined deficiency of vitamin K-dependent clotting factors to the centromeric region of chromosome 16. Blood 100 (2002) 3229-3232
27. Fridell Y.W., Villa Jr. J., Attar E.C., and Liu E.T. GAS6 induces Axl-mediated chemotaxis of vascular smooth muscle cells. J. Biol. Chem. 273 (1998) 7123-7126
28. Friedman P.A., and Shia M. Some characteristics of a vitamin K-dependent carboxylating system from rat liver microsomes. Biochem. Biophys. Res. Commun. 70 (1976) 647-654
29. Furie B.C., Ratcliffe J.V., Tward J., Jorgensen M.J., Blaszkowsky L.S., DiMichele D., and Furie B. The gamma-carboxylation recognition site is sufficient to direct vitamin K-dependent carboxylation on an adjacent glutamate-rich region of thrombin in a propeptide-thrombin chimera. J. Biol. Chem. 272 (1997) 28258-28262
30. Furie B., Bouchard B.A., and Furie B.C. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood 93 (1999) 1798-1808
31. Goodstadt L., and Ponting C.P. Vitamin K epoxide reductase: Homology, active site and catalytic mechanism. Trends Biochem. Sci. 29 (2004) 289-292
32. Goruppi S., Ruaro E., Varnum B., and Schneider C. Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3T3 fibroblasts. Mol. Cell. Biol. 17 (1997) 4442-4453
33. Hallgren K.W., Hommema E.L., McNally B.A., and Berkner K.L. Carboxylase overexpression impairs factor IX secretion: Implications for the release of vitamin K-dependent proteins. Biochemistry 41 (2002) 15045-15055
34. Hallgren K.W., Qian W., Yakubenko A.V., Runge K.W., and Berkner K.L. r-VKORC1 expression in factor IX BHK cells increases the extent of factor IX carboxylation but is limited by saturation of another carboxylation component or by a shift in the rate-limiting step. Biochemistry 45 (2006) 5587-5598
35. Hammond C., and Helenius A. Quality control in the secretory pathway. Curr. Opin. Cell Biol. 7 (1995) 523-529
36. Harrington D.J., Underwood S., Morse C., Shearer M.J., Tuddenham E.G., and Mumford A.D. Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in vitamin K epoxide reductase complex subunit 1. Thromb. Haemost. 93 (2005) 23-26
37. Hasanbasic I., Rajotte I., and Blostein M. The role of gamma-carboxylation in the anti-apoptotic function of gas6. J. Thromb. Haemost. 3 (2005) 2790-2797
38. Hedner U. Recombinant factor VIIa (Novoseven) as a hemostatic agent. Semin. Hematol. 38 (2001) 43-47
39. Hirsh J., Dalen J., Anderson D.R., Poller L., Bussey H., Ansell J., and Deykin D. Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 119 (2001) 8S-21S
40. Houben R.J., Jin D., Stafford D.W., Proost P., Ebberink R.H., Vermeer C., and Soute B.A. Osteocalcin binds tightly to the gamma-glutamylcarboxylase at a site distinct from that of the other known vitamin K-dependent proteins. Biochem. J. 341 (1999) 265-269
41. Jiang Y., and Doolittle R.F. The evolution of vertebrate blood coagulation as viewed from a comparison of puffer fish and sea squirt genomes. Proc. Natl. Acad. Sci. USA 100 (2003) 7527-7532
42. Knobloch J.E., and Suttie J.W. Vitamin K-dependent carboxylase. Control of enzyme activity by the propeptide: Region of factor X. J. Biol. Chem. 262 (1987) 15334-15337
43. Kulman J.D., Harris J.E., Haldeman B.A., and Davie E.W. Primary structure and tissue distribution of two novel proline-rich gamma-carboxyglutamic acid proteins. Proc. Natl. Acad. Sci. USA 94 (1997) 9058-9062
44. Kulman J.D., Harris J.E., Xie L., and Davie E.W. Identification of two novel transmembrane gamma-carboxyglutamic acid proteins expressed broadly in fetal and adult tissues. Proc. Natl. Acad. Sci. USA 98 (2001) 1370-1375
45. Kulman J.D., Harris J.E., Nakazawa N., Ogasawara M., Satake M., and Davie E.W. Vitamin K-dependent proteins in Ciona intestinalis, a basal chordate lacking a blood coagulation cascade. Proc. Natl. Acad. Sci. USA 103 (2006) 15794-15799
46. Li T., Yang C.T., Jin D., and Stafford D.W. Identification of a Drosophila vitamin K-dependent gamma-glutamyl carboxylase. J. Biol. Chem. 275 (2000) 18291-18296
47. Li J., Lin J.C., Wang H., Peterson J.W., Furie B.C., Furie B., Booth S.L., Volpe J.J., and Rosenberg P.A. Novel role of vitamin K in preventing oxidative injury to developing oligodendrocytes and neurons. J. Neurosci. 23 (2003) 5816-5826
48. Li T., Chang C.Y., Jin D.Y., Lin P.J., Khvorova A., and Stafford D.W. Identification of the gene for vitamin K epoxide reductase. Nature 427 (2004) 541-544
49. Lin P.J., Jin D.Y., Tie J.K., Presnell S.R., Straight D.L., and Stafford D.W. The putative vitamin K-dependent gamma-glutamyl carboxylase internal propeptide appears to be the propeptide binding site. J. Biol. Chem. 277 (2002) 28584-28591
50. Lin P.J., Straight D.L., and Stafford D.W. Binding of the factor IX gamma-carboxyglutamic acid domain to the vitamin K-dependent gamma-glutamyl carboxylase active site induces an allosteric effect that may ensure processive carboxylation and regulate the release of carboxylated product. J. Biol. Chem. 279 (2004) 6560-6566
51. Lind S.E., Callas P.W., Golden E.A., Joyner Jr. K.A., and Ortel T.L. Plasma levels of factors II, VII, and X and their relationship to the international normalized ratio during chronic warfarin therapy. Blood Coagul. Fibrinolysis 8 (1997) 48-53
52. Liska D.J., and Suttie J.W. Location of gamma-carboxyglutamyl residues in partially carboxylated prothrombin preparations. Biochemistry 27 (1988) 8636-8641
53. Luo G., Ducy P., McKee M.D., Pinero G.J., Loyer E., Behringer R.R., and Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386 (1997) 78-81
54. Mack D.O., Suen E.T., Girardot J.M., Miller J.A., Delaney R., and Johnson B.C. Soluble enzyme system for vitamin K-dependent carboxylation. J. Biol. Chem. 251 (1976) 3269-3276
55. Malhotra O.P. Atypical prothrombins induced by dicoumarol. Nat. New Biol. 239 (1972) 59-60
56. Manfioletti G., Brancolini C., Avanzi G., and Schneider C. The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol. Cell. Biol. 13 (1993) 4976-4985
57. Mark M.R., Chen J., Hammonds R.G., Sadick M., and Godowsk P.J. Characterization of Gas6, a member of the superfamily of G domain-containing proteins, as a ligand for Rse and Axl. J. Biol. Chem. 271 (1996) 9785-9789
58. Morris D.P., Stevens R.D., Wright D.J., and Stafford D.W. Processive post-translational modification. Vitamin K-dependent carboxylation of a peptide substrate. J. Biol. Chem. 270 (1995) 30491-30498
59. Munroe P.B., Olgunturk R.O., Fryns J.P., Van Maldergem L., Ziereisen F., Yuksel B., Gardiner R.M., and Chung E. Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat. Genet. 21 (1999) 142-144
60. Mutucumarana V.P., Stafford D.W., Stanley T.B., Jin D.Y., Solera J., Brenner B., Azerad R., and Wu S.M. Expression and characterization of the naturally occurring mutation L394R in human gamma-glutamyl carboxylase. J. Biol. Chem. 275 (2000) 32572-32577
61. Mutucumarana V.P., Acher F., Straight D.L., Jin D.Y., and Stafford D.W. A conserved region of human vitamin K-dependent carboxylase between residues 393 and 404 is important for its interaction with the glutamate substrate. J. Biol. Chem. 278 (2003) 46488-46493
62. Nakano T., Kawamoto K., Higashino K., and Arita H. Prevention of growth arrest-induced cell death of vascular smooth muscle cells by a product of growth arrest-specific gene, gas6. FEBS Lett. 387 (1996) 78-80
63. Nakano T., Kawamoto K., Kishino J., Nomura K., Higashino K., and Arita H. Requirement of gamma-carboxyglutamic acid residues for the biological activity of Gas6: Contribution of endogenous Gas6 to the proliferation of vascular smooth muscle cells. Biochem. J. 323 (1997) 387-392
64. Oldenburg J., Quenzel E.M., Harbrecht U., Fregin A., Kress W., Muller C.R., Hertfelder H.J., Schwaab R., Brackmann H.H., and Hanfland P. Missense mutations at ALA-10 in the factor IX propeptide: An insignificant variant in normal life but a decisive cause of bleeding during oral anticoagulant therapy. Br. J. Haematol. 98 (1997) 240-244
65. Olivera B.M., Gray W.R., Zeikus R., McIntosh J.M., Varga J., Rivier J., de Santos V., and Cruz L.J. Peptide neurotoxins from fish-hunting cone snails. Science 230 (1985) 1338-1343
66. Poser J.W., and Price P.A. A method for decarboxylation of gamma-carboxyglutamic acid in proteins. Properties of the decarboxylated gamma-carboxyglutamic acid protein from calf bone. J. Biol. Chem. 254 (1979) 431-436
67. Presnell S.R., Tripathy A., Lentz B.R., Jin D.Y., and Stafford D.W. A novel fluorescence assay to study propeptide interaction with gamma-glutamyl carboxylase. Biochemistry 40 (2001) 11723-11733
68. Price P.A., and Williamson M.K. Effects of warfarin on bone. Studies on the vitamin K-dependent protein of rat bone. J. Biol. Chem. 256 (1981) 12754-12759
69. Price P.A., and Williamson M.K. Substrate recognition by the vitamin K-dependent gamma-glutamyl carboxylase: Identification of a sequence homology between the carboxylase and the carboxylase recognition site in the substrate. Protein Sci. 2 (1993) 1987-1988
70. Price P.A., Fraser J.D., and Metz V.G. Molecular cloning of matrix Gla protein: Implications for substrate recognition by the vitamin K-dependent gamma-carboxylase. Proc. Natl. Acad. Sci. USA 84 (1987) 8335-8339
71. Price P.A., Faus S.A., and Williamson M.K. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 1400-1407
72. Pudota B.N., Miyagi M., Hallgren K.W., West K.A., Crabb J.W., Misono K.S., and Berkner K.L. Identification of the vitamin K-dependent carboxylase active site: Cys-99 and Cys-450 are required for both epoxidation and carboxylation. Proc. Natl. Acad. Sci. USA 97 (2000) 13033-13038
73. Pudota B.N., Hommema E.L., Hallgren K.W., McNally B.A., Lee S., and Berkner K.L. Identification of sequences within the γ-carboxylase that represent a novel contact site with vitamin K-dependent proteins and that are required for activity. J. Biol. Chem. 276 (2001) 46878-46886
74. Ratcliffe J.V., Furie B., and Furie B.C. The importance of specific gamma-carboxyglutamic acid residues in prothrombin. Evaluation by site-specific mutagenesis. J. Biol. Chem. 268 (1993) 24339-24345
75. Rehemtulla A., Roth D.A., Wasley L.C., Kuliopulos A., Walsh C.T., Furie B., Furie B.C., and Kaufman R.J. In vitro and in vivo functional characterization of bovine vitamin K-dependent gamma-carboxylase expressed in Chinese hamster ovary cells. Proc. Natl. Acad. Sci. USA 90 (1993) 4611-4615
76. Rishavy M.A., Pudota B.N., Hallgren K.W., Qian W., Yakubenko A.V., Song J.H., Runge K.W., and Berkner K.L. A new model for vitamin K-dependent carboxylation: The catalytic base that deprotonates vitamin K hydroquinone is not Cys but an activated amine. Proc. Natl. Acad. Sci. USA 101 (2004) 13732-13737
77. Rishavy M.A., Hallgren K.W., Yakubenko A.V., Zuerner R.L., Runge K.W., and Berkner K.L. The vitamin K-dependent carboxylase has been acquired by Leptospira pathogens and shows altered activity that suggests a role other than protein carboxylation. J. Biol. Chem. 280 (2005) 34870-34877
78. Rishavy M.A., Hallgren K.W., Yakubenko A.V., Shtofman R.L., Runge K.W., and Berkner K.L. Bronsted analysis reveals Lys218 as the carboxylase active site base that deprotonates vitamin K hydroquinone to initiate vitamin K-dependent protein carboxylation. Biochemistry 45 (2006) 13239-13248
79. Roberts H.R., Monroe D.M., and White G.C. The use of recombinant factor VIIa in the treatment of bleeding disorders. Blood 104 (2004) 3858-3864
80. Ronden J.E., Drittij-Reijnders M.J., Vermeer C., and Thijssen H.H.W. Intestinal flora is not an intermediate in the phylloquinone-menaquinone-4 conversion in the rat. Biochim. Biophys. Acta 1379 (1998) 69-75
81. Rong Y.S., Titen S.W., Xie H.B., Golic M.M., Bastiani M., Bandyopadhyay P., Olivera B.M., Brodsky M., Rubin G.M., and Golic K.G. Targeted mutagenesis by homologous recombination in D. melanogaster. Genes Dev. 16 (2002) 1568-1581
82. Rost S., Fregin A., Ivaskevicius V., Conzelmann E., Hortnagel K., Pelz H.J., Lappegard K., Seifried E., Scharrer I., Tuddenham E.G., Muller C.R., Strom T.M., et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 427 (2004) 537-541
83. Rost S., Fregin A., Koch D., Compes M., Muller C.R., and Oldenburg J. Compound heterozygous mutations in the gamma-glutamyl carboxylase gene cause combined deficiency of all vitamin K-dependent blood coagulation factors. Br. J. Haematol. 126 (2004) 546-549
84. Rost S., Fregin A., Hunerberg M., Bevans C.G., Muller C.R., and Oldenburg J. Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: Evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin. Thromb. Haemost. 94 (2005) 780-786
85. Roth D.A., Whirl M.L., Velazquez-Estades L.J., Walsh C.T., Furie B., and Furie B.C. Mutagenesis of vitamin K-dependent carboxylase demonstrates a carboxyl terminus-mediated interaction with vitamin K hydroquinone. J. Biol. Chem. 270 (1995) 5305-5311
86. Schmidt-Krey I., Haase W., Mutucumarana V., Stafford D.W., and Kuhlbrandt W. Two-dimensional crystallization of human vitamin K-dependent gamma-glutamyl carboxylase. J. Struct. Biol. 157 (2007) 437-442
87. Schultz J. HTTM, a horizontally transferred transmembrane domain. Trends Biochem. Sci. 29 (2004) 4-7
88. Silverman R.B., and Nandi D.L. Reduced thioredoxin: A possible physiological cofactor for vitamin K epoxide reductase. Further support for an active site disulfide. Biochem. Biophys. Res. Commun. 155 (1988) 1248-1254
89. Souri M., Koseki-Kuno S., Iwata H., Kemkes-Matthes B., and Ichinose A. A naturally occurring E30Q mutation in the Gla domain of protein Z causes its impaired secretion and subsequent deficiency. Blood 105 (2005) 3149-3154
90. Soute B.A., Ulrich M.M., Watson A.D., Maddison J.E., Ebberink R.H., and Vermeer C. Congenital deficiency of all vitamin K-dependent blood coagulation factors due to a defective vitamin K-dependent carboxylase in Devon Rex cats. Thromb. Haemost. 68 (1992) 521-525
91. Soute B.A., Jin D.Y., Spronk H.M., Mutucumarana V.P., Lin P.J., Hackeng T.M., Stafford D.W., and Vermeer C. Characteristics of recombinant W501S mutated human gamma-glutamyl carboxylase. J. Thromb. Haemost. 2 (2004) 597-604
92. Spronk H.M., Farah R.A., Buchanan G.R., Vermeer C., and Soute B.A. Novel mutation in the gamma-glutamyl carboxylase gene resulting in congenital combined deficiency of all vitamin K-dependent blood coagulation factors. Blood 96 (2000) 3650-3652
93. Spronk H.M., Soute B.A., Schurgers L.J., Thijssen H.H., De Mey J.G., and Vermeer C. Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats. J. Vasc. Res. 40 (2003) 531-537
94. Stanley T.B., Humphries J., High K.A., and Stafford D.W. Amino acids responsible for reduced affinities of vitamin K-dependent propeptides for the carboxylase. Biochemistry 38 (1999) 15681-15687
95. Stanley T.B., Jin D.Y., Lin P.J., and Stafford D.W. The propeptides of the vitamin K-dependent proteins possess different affinities for the vitamin K-dependent carboxylase. J. Biol. Chem. 274 (1999) 16940-16944
96. Stenhoff J., Dahlback B., and Hafizi S. Vitamin K-dependent Gas6 activates ERK kinase and stimulates growth of cardiac fibroblasts. Biochem. Biophys. Res. Commun. 319 (2004) 871-878
97. Stenina O., Pudota B.N., McNally B.A., Hommema E.L., and Berkner K.L. Tethered processivity of the vitamin K-dependent carboxylase: Factor IX is efficiently modified in a mechanism which distinguishes Gla's from Glu's and which accounts for comprehensive carboxylation in vivo. Biochemistry 40 (2001) 10301-10309
98. Sugiura I., Furie B., Walsh C.T., and Furie B.C. Propeptide and glutamate-containing substrates bound to the vitamin K-dependent carboxylase convert its vitamin K epoxidase function from an inactive to an active state. Proc. Natl. Acad. Sci. USA 94 (1997) 9069-9074
99. Sun Y.M., Jin D.Y., Camire R.M., and Stafford D.W. Vitamin K epoxide reductase significantly improves carboxylation in a cell line overexpressing factor X. Blood 106 (2005) 3811-3815
100. Suttie J.W. Vitamin K-dependent carboxylase. Annu. Rev. Biochem. 54 (1985) 459-477
101. Suttie J.W. The importance of menaquinones in human nutrition. Annu. Rev. Nutr. 15 (1995) 399-417
102. Suttie J.W., Lehrman S.R., Geweke L.O., Hageman J.M., and Rich D.H. Vitamin K-dependent carboxylase: Requirements for carboxylation of soluble peptide and substrate specificity. Biochem. Biophys. Res. Commun. 86 (1979) 500-507
103. Tabb M.M., Sun A., Zhou C., Grun F., Errandi J.L., Romero K.M., Pham H., Inoue S., Mallick S., Lin M., Forman B.M., and Blumberg B. Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor, SXR. J. Biol. Chem. 278 (2003) 43919-43927
104. Thijssen H.H., and Drittij-Reijnders M.J. Vitamin K status in human tissues: Tissue-specific accumulation of phylloquinone and menaquinone-4. Br. J. Nutr. 75 (1996) 121-127
105. Thijssen H.H., Janssen Y.P., and Vervoort L.T. Microsomal lipoamide reductase provides vitamin K epoxide reductase with reducing equivalents. Biochem. J. 297 (1994) 277-280
106. Tie J., Wu S.M., Jin D., Nicchitta C.V., and Stafford D.W. A topological study of the human gamma-glutamyl carboxylase. Blood 96 (2000) 973-978
107. Tie J.K., Nicchitta C., von Heijne G., and Stafford D.W. Membrane topology mapping of vitamin K epoxide reductase by in vitro translation/cotranslocation. J. Biol. Chem. 280 (2005) 16410-16416
108. Tokunaga F., Wakabayashi S., and Koide T. Warfarin causes the degradation of protein C precursor in the endoplasmic reticulum. Biochemistry 34 (1995) 1163-1170
109. Vanakker O.M., Martin L., Gheduzzi D., Leroy B.P., Loeys B.L., Guerci V.I., Matthys D., Terry S.F., Coucke P.J., Pasquali-Ronchetti I., and De Paepe A. Pseudoxanthoma elasticum-like phenotype with cutis laxa and multiple coagulation factor deficiency represents a separate genetic entity. J. Invest. Dermatol. 127 (2007) 581-587
110. Wajih N., Hutson S.M., Owen J., and Wallin R. Increased production of functional recombinant human clotting factor IX by baby hamster kidney cells engineered to overexpress VKORC1, the vitamin K 2,3-epoxide-reducing enzyme of the vitamin K cycle. J. Biol. Chem. 280 (2005) 31603-31607
111. Walker C.S., Shetty R.P., Clark K.A., Kazuko S.G., Letsou A., Olivera B.M., and Bandyopadhyay P.K. On a potential global role for vitamin K-dependent gamma-carboxylation in animal systems: Evidence for a gamma-glutamyl carboxylase in Drosophila. J. Biol. Chem. 276 (2001) 7769-7774
112. Wang C.P., Yagi K., Lin P.J., Jin D.Y., Makabe K.W., and Stafford D.W. Identification of a gene encoding a typical gamma-carboxyglutamic acid domain in the tunicate Halocynthia roretzi. J. Thromb. Haemost. 1 (2003) 118-123
113. White G., Shapiro A., Ragni M., Garzone P., Goodfellow J., Tubridy K., and Courter S. Clinical evaluation of recombinant factor IX. Semin. Hematol. 35 (1998) 33-38
114. Whitlon D.S., Sadowski J.A., and Suttie J.W. Mechanism of coumarin action: Significance of vitamin K epoxide reductase inhibition. Biochemistry 17 (1978) 1371-1377
115. Wu S.M., Cheung W.F., Frazier D., and Stafford D.W. Cloning and expression of the cDNA for human gamma-glutamyl carboxylase. Science 254 (1991) 1634-1636
116. Wu S.M., Stafford D.W., Frazier L.D., Fu Y.Y., High K.A., Chu K., Sanchez-Vega B., and Solera J. Genomic sequence and transcription start site for the human gamma-glutamyl carboxylase. Blood 89 (1997) 4058-4062
117. Zhang L., Jhingan A., and Castellino F.J. Role of individual gamma-carboxyglutamic acid residues of activated human protein C in defining its in vitro anticoagulant activity. Blood 80 (1992) 942-952
118. Zhu A., Sun H., Raymond Jr. R.M., Furie B.C., Furie B., Bronstein M., Kaufman R.J., Westrick R., and Ginsburg D. Fatal hemorrhage in mice lacking {gamma}-glutamyl carboxylase. Blood. 109 (1991) 5270-5275